ImmunoSEB + ProbioSEB CSC3 for post-resolution of mild to moderate COVID-19 patients Mumbai, Maharashtra [India], June 21: According to recent stats, 2.77 crores of
ImmunoSEB + ProbioSEB CSC3 for post-resolution of mild to moderate COVID-19 patients Mumbai, Maharashtra [India], June 21: According to recent stats, 2.77 crores of
